Mikako Ogawa

10.6k total citations · 3 hit papers
157 papers, 8.7k citations indexed

About

Mikako Ogawa is a scholar working on Molecular Biology, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mikako Ogawa has authored 157 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 53 papers in Biomedical Engineering and 43 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mikako Ogawa's work include Nanoplatforms for cancer theranostics (50 papers), Photodynamic Therapy Research Studies (32 papers) and Cancer Research and Treatments (15 papers). Mikako Ogawa is often cited by papers focused on Nanoplatforms for cancer theranostics (50 papers), Photodynamic Therapy Research Studies (32 papers) and Cancer Research and Treatments (15 papers). Mikako Ogawa collaborates with scholars based in Japan, United States and India. Mikako Ogawa's co-authors include Hisataka Kobayashi, Peter L. Choyke, Yasuteru Urano, Nobuyuki Kosaka, Raphael Alford, Makoto Mitsunaga, Yasuhiro Magata, Lauren Rosenblum, Michelle Longmire and Celeste A.S. Regino and has published in prestigious journals such as Chemical Reviews, Chemical Society Reviews and Nature Medicine.

In The Last Decade

Mikako Ogawa

151 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging

2009 1.9k citations Hisataka Kobayashi, Mikako Ogawa et al. profile →
Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules

2011 856 citations Makoto Mitsunaga, Mikako Ogawa et al. profile →
Sensitive β-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo

2015 357 citations Mikako Ogawa, Nobuyuki Kosaka et al. profile →

Peers

Countries citing papers authored by Mikako Ogawa

Since Specialization

Citations

This map shows the geographic impact of Mikako Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikako Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikako Ogawa more than expected).

Fields of papers citing papers by Mikako Ogawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikako Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikako Ogawa. The network helps show where Mikako Ogawa may publish in the future.

Co-authorship network of co-authors of Mikako Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mikako Ogawa. A scholar is included among the top collaborators of Mikako Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikako Ogawa. Mikako Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histopathological analysis of tumor microenvironmental changes after near-infrared photoimmunotherapy 2025 ·Journal of Oral and Maxillofacial Surgery Medicine and Pathology ·(unknown), Aya Matsuda, Nako Maishi, Kohei Nakajima, (unknown), (unknown), Yoichi Ohiro, Mikako Ogawa, Yasuhiro Hida, Kyoko Hida	0
2	Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties 2025 ·Nuclear Medicine and Biology ·(unknown), Atsushi B. Tsuji, Yutian Feng, Yongxiang Zheng, Hitomi Sudo, Aya Sugyo, W. Tornow, (unknown), Katsuyuki Minegishi, Hisashi Suzuki, (unknown), Mikako Ogawa, Ming‐Rong Zhang, Michael R. Zalutsky	1
3	Investigation of the substituent effect of indocyanine green derivatives for lymph imaging 2024 ·Bioorganic & Medicinal Chemistry ·Naoya Ieda, Hideo Takakura, (unknown), Takayuki Ohira, (unknown), Kohei Nakajima, Mikako Ogawa	1
4	Theoretical Design and Synthesis of Caged Compounds Using X‐Ray‐Triggered Azo Bond Cleavage 2024 ·Advanced Science ·(unknown), Osamu Inanami, Hideo Takakura, Kenichiro Saita, Kohei Nakajima, Sonu Kumar, Naoya Ieda, Masato Kobayashi, Tetsuya Taketsugu, Mikako Ogawa	5
5	X-ray photoemission and absorption spectroscopy of a hypervalent iodine compound, 2-iodosobenzoic acid 2023 ·Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms ·(unknown), (unknown), Kentaro Fujii, Akinari Yokoya, Mikako Ogawa	0
6	X-ray irradiation-induced ligand cleavage of a phthalocyanine derivative, tin (IV) phthalocyanine dichloride: A potential for X-ray activation of caged compounds 2023 ·Chemical Physics Letters ·(unknown), (unknown), Kentaro Fujii, Akinari Yokoya, Mikako Ogawa	1
7	Novel Auger-Electron-Emitting 191Pt-Labeled Pyrrole–Imidazole Polyamide Targeting MYCN Increases Cytotoxicity and Cytosolic dsDNA Granules in MYCN-Amplified Neuroblastoma 2023 ·Pharmaceuticals ·(unknown), Atsushi B. Tsuji, Hitomi Sudo, Aya Sugyo, Kaori Hashiya, Hayato Ikeda, Masatoshi Itoh, Katsuyuki Minegishi, Kotaro Nagatsu, Mikako Ogawa, Toshikazu Bando, Hiroshi Sugiyama, Ming‐Rong Zhang	2
8	Development of Novel ¹⁹¹Pt-Labeled Hoechst33258: ¹⁹¹Pt Is More Suitable than ¹¹¹In for Targeting DNA 2022 ·Journal of Medicinal Chemistry ·(unknown), Atsushi B. Tsuji, Katsushi Kumata, Hitomi Sudo, Katsuyuki Minegishi, Kotaro Nagatsu, Hideo Takakura, Mikako Ogawa, Akihiro Kurimasa, Ming‐Rong Zhang	5
9	In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([189, 191Pt]cisplatin) Emitting Auger Electrons 2021 ·International Journal of Molecular Sciences ·(unknown), Atsushi B. Tsuji, Hitomi Sudo, Aya Sugyo, Katsuyuki Minegishi, Kotaro Nagatsu, Mikako Ogawa, Ming‐Rong Zhang	9
10	Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity 2017 ·Oncotarget ·Mikako Ogawa, Yusuke Tomita, Yuko Nakamura, Min-Jung Lee, Sunmin Lee, Saori Tomita, Tadanobu Nagaya, Kazuhide Sato, Toyohiko Yamauchi, Hidenao Iwai, Abhishek Kumar, Timothy Haystead, Hari Shroff, Peter L. Choyke, Jane B. Trepel, Hisataka Kobayashi	195
11	Prolonged local retention of subcutaneously injected polymers monitored by noninvasive SPECT imaging 2014 ·International Journal of Pharmaceutics ·Chie Kojima, (unknown), Mikako Ogawa, Yasuhiro Magata	9
12	Assessment of epidermal growth factor receptor status in glioblastomas. 2013 ·SHILAP Revista de lepidopterología ·Huijun Zhu, Mikako Ogawa, Yasuhiro Magata, Masahiko Hirata, Yoshiro Ohmomo, Hiroki Namba, Harumi Sakahara	3
13	Development of¹¹¹In-Labeled Liposomes for Vulnerable Atherosclerotic Plaque Imaging 2013 ·Journal of Nuclear Medicine ·Mikako Ogawa, Izumi O. Umeda, (unknown), (unknown), (unknown), (unknown), Yin Hongxia, Takayuki Kudoh, Masaharu Seno, Yasuhiro Magata	37
14	High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation 2010 ·Molecular BioSystems ·Mikako Ogawa, Nobuyuki Kosaka, Celeste A.S. Regino, Makoto Mitsunaga, Peter L. Choyke, Hisataka Kobayashi	49
15	In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies 2009 ·Molecular Cancer Therapeutics ·Mikako Ogawa, Celeste A.S. Regino, Peter L. Choyke, Hisataka Kobayashi	78
16	Molecular probes for the in vivo imaging of cancer 2009 ·Molecular BioSystems ·Raphael Alford, Mikako Ogawa, Peter L. Choyke, Hisataka Kobayashi	57
17	H-Type Dimer Formation of Fluorophores: A Mechanism for Activatable, in Vivo Optical Molecular Imaging 2009 ·ACS Chemical Biology ·Mikako Ogawa, Nobuyuki Kosaka, Peter L. Choyke, Hisataka Kobayashi	166
18	New Approaches to Lymphatic Imaging 2009 ·Lymphatic Research and Biology ·(unknown), Mikako Ogawa, Nobuyuki Kosaka, Barış Türkbey, Hisataka Kobayashi, Peter L. Choyke	39
19	Dual-Modality Molecular Imaging Using Antibodies Labeled with Activatable Fluorescence and a Radionuclide for Specific and Quantitative Targeted Cancer Detection 2009 ·Bioconjugate Chemistry ·Mikako Ogawa, Celeste A.S. Regino, Jürgen Seidel, Michael V. Green, (unknown), Mark R. Williams, Nobuyuki Kosaka, Peter L. Choyke, Hisataka Kobayashi	82
20	Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl-1,3-dihydro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography 2002 ·Nuclear Medicine and Biology ·Mikako Ogawa, Kentaro Hatano, Yasuhiro Kawasumi, Kiichi Ishiwata, Kazunori Kawamura, Satoshi Ozaki, Kengo Ito	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact